Overview

The Pharmacokinetics of Dexmedetomidine in Children

Status:
Terminated
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to identify the plasma concentrations which are required to achieve adequate sedation, using a Ramsay Sedation Scale. As an alpha 2 agonist, dexmedetomidine can elicit hemodynamic changes, fluctuations in blood pressure and heart rate. This study will attempt to determine whether these changes can be predicted by plasma concentrations.
Details
Lead Sponsor:
Boston Children's Hospital
Boston Children’s Hospital
Treatments:
Dexmedetomidine